CBD Products Inc. has announced the launch of 'Cannabinoid Balance Pain Relief Cream+,' a deep-penetrating and fast-acting CBD-based product designed to treat a variety of pain-related ailments. These include muscle pain, joint pain, circulation issues, arthritis, dry and sore skin, and tendonitis.
This all-natural cream was created using NanoZorb™ Technology, an innovative system capable of boosting the product's ability to stimulate the body's endocannabinoid system, effectively reducing pain and inflammation. The endocannabinoid system is a "biochemical communication system in our bodies that helps regulate everything from nerve function and muscle coordination to immunity and blood circulation" says Anthony Tribunella, CEO of CBD Products Inc.
The 'Cannabinoid Balance Pain Relief Cream+,' is the ideal product for those suffering from pain-related symptoms, but who are wary of strong chemical-based products.
CBD Pain Relief Creams
CBD Products Launches 'Cannabinoid Balance Pain Relief Cream+'
Trend Themes
1. Nanozorb™ Technology - NanoZorb™ Technology creates opportunities for the development of new and innovative CBD-based products.
2. CBD Pain Relief Creams - CBD Pain Relief Creams present an attractive alternative to traditional, chemical-based pain relief products.
3. Endocannabinoid System - The endocannabinoid system presents an opportunity for the development of targeted CBD-based products for a variety of ailments.
Industry Implications
1. Pharmaceuticals - Pharmaceutical companies can utilize NanoZorb™ Technology and the endocannabinoid system to create new pain relief products and disrupt the traditional pain relief market.
2. Beauty and Skincare - Beauty and skincare companies can incorporate CBD-based products with NanoZorb™ Technology to create natural and effective remedies for dry and sore skin.
3. Fitness and Athletic - Fitness and athletic companies can use CBD-based products with NanoZorb™ Technology to develop products targeted at treating muscle and joint pain for athletes and fitness enthusiasts.